Valve Chronicles: Preventative Maintenance

 

For any parts in a mechanical process, preventative maintenance is critical for a longer, useful life. That’s true for valves in water systems. On Valve Chronicles, host Tyler Kern spoke with Jake Corzine, Western Regional Manager, Cla-Val, and Randy Harris, EMT Superintendent, California Water, about the subject.

Harris’ role with Cal Water is to manage a network that maintains electrical and mechanical systems, including valves. He explained the different types, “We use altitude, pressure reducing, pressure, release, and pump control. Additionally, sometimes there are combination valves.”

In Harris’ area, which includes 1750 valves, it’s a tall order to keep them in top shape. He shared that some are as old as 1953, while they just installed a new one. So, how do they service all these valves?

Harris answered, “We are constantly checking the condition to ensure something that’s worn out is replaced before failure.”

They use a computerized maintenance management system that includes all the valves and have a five-year cycle for each one. Corzine commented, “Cal Water has also standardized each type of valve, which helps with maintenance.”

Replacement versus fixing is another consideration. “It’s the age and condition. We look at the inside of the valve. Before the mid-90s, they didn’t have an epoxy coating, so rust builds up and has to be scraped away, which makes the body thinner,” Harris said.

Corzine noted that Cal Water has an excellent maintenance program and encouraged all organizations to “allocate funds and time to this because it prolongs the life of the valve.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More